Cargando…
β-elemene combined with temozolomide in treatment of brain glioma
Temozolomide (TMZ) is a widely used chemotherapeutic agent for malignant glioma. β-Elemene has been reported to have the ability of passing through the blood-brain barrier and reverse multidrug resistance. In the present study, transport of drugs through the in vitro blood-brain barrier (BBB) model...
Autores principales: | Zhang, Xiaomin, Chen, Yidan, Yao, Ju, Zhang, Yingxin, Li, Mengying, Yu, Bo, Wang, Kaifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482427/ https://www.ncbi.nlm.nih.gov/pubmed/34622038 http://dx.doi.org/10.1016/j.bbrep.2021.101144 |
Ejemplares similares
-
Combinative effects of β-elemene and propranolol on the proliferation, migration, and angiogenesis of hemangioma
por: Wang, Zhenyu, et al.
Publicado: (2023) -
Beneficial Effect of β-Elemene Alone and in Combination with Hyperbaric Oxygen in Traumatic Brain Injury by Inflammatory Pathway
por: Meng, Xiangen, et al.
Publicado: (2018) -
Second generation β-elemene nitric oxide derivatives with reasonable linkers: potential hybrids against malignant brain glioma
por: Bai, Renren, et al.
Publicado: (2022) -
Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy
por: Zhai, Bingtao, et al.
Publicado: (2018) -
β‐Elemene Selectively Inhibits the Proliferation of Glioma Stem‐Like Cells Through the Downregulation of Notch1
por: Feng, Hai‐bin, et al.
Publicado: (2016)